RHEI Pharmaceuticals, Inc., a US company that seeks to bring proprietary medications to China, licensed the China marketing rights for Attental from MethaPharma. Attental is a nutraceutical drug available in Europe to treat symptoms of ADHD in children. MethaPharma, a division of Vemedia Group, is headquartered in Belgium. More details...
